Overview Fundamentals API Earnings EOD API Sample Code Pricing

ImmuCell Corporation (ICCC NASDAQ) stock market data APIs

$4.1239 0.07(1.7%) as of July 26, 2024
Price chart is built with Anychart

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

ImmuCell Corporation Financial Data Overview

4.05
4.1239
-
4.1239
4.05
4.02-5.64
32 497 K
7 812 K
21 283 K
-0.0565
0.588
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ICCC',
Type: 'Common Stock',
Name: 'ImmuCell Corporation',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BLQ5Q2',
ISIN: NULL,
CUSIP: NULL,
CIK: '811641',
EmployerIdNumber: '01-0382980',
FiscalYearEnd: 'December',
IPODate: '1987-04-30',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

ImmuCell Corporation Fundamental Data is available in our Financial Data APIs

  • Net Revenue 21 283 K
  • EBITDA -537 747
  • Earnings Per Share -0.51
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get ImmuCell Corporation Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast NaN

Get ImmuCell Corporation End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com